Sep 15, 2021 / 02:55PM GMT
Unidentified Participant
This webcast presentation is for Bank of America clients only. If you are a member or a representative of the media or press, please disconnect now.
Jason Gerberry - Bank of America - Analyst
Good day, everybody. My name is Jason Gerberry; I am one of the biotech analysts at Bank of America. I am pleased to be introducing our next company presenter, Ionis and CFO Beth Hougen. So, Beth, first off, thanks for joining us at the conference once again virtually.
Beth Hougen - Ionis Pharmaceuticals, Inc. - EVP & CFO
Thank you for having us. We are glad to be here. Happy to be here.
Questions and Answers:
Jason Gerberry - Bank of America - AnalystGreat, great. Well look, the Company has been a leader in the RNAi space -- or the RNA interfering space for quite some time. And maybe -- you had a lot of interesting success with Spinraza, and I'm curious if you can talk a little bit about what you see as some of the next key inflection points in the story,
Trustpilot
